🟢 Taysha Gene Therapies is trading 6.28% up in pre-market with no clear catalyst identified

Taysha Gene Therapies is trading at $4.40, up +6.28% pre-market on October 13, 2026, with no clear company-specific catalyst identified.

• Shares closed at $4.14 on October 12.
• The latest listed company release was an October 2 employee inducement grant; the investor-relations page shows no newer release.
• Nasdaq futures were lower while the S&P 500 was nearly unchanged. Available evidence does not establish why shares are moving higher.